Antiglycation Activity of Otostegia persica (Burm.) Boiss

African Journal of Biotechnology

Volumn 9, Issue 24, 2010, Pages 3645-3648

  Ayatollahi, Seyed Abdul Majid ^a   Kobarfard, Farzad ^a   Asgarpanah, Jinous ^b   Choudhary, Muhammad Iqbal ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

3 ,7 dihydroxy 4 ,6,8 trimethoxy flavone; Antiglycation; Otostegia persica

Indexed keywords

3',7 DIHYDROXY 4',6,8 TRIMETHOXYFLAVONE; ADVANCED GLYCATION END PRODUCT; PLANT MEDICINAL PRODUCT; RUTOSIDE; UNCLASSIFIED DRUG;

ANGIOSPERM; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; GLYCATION; OTOSTEGIA PERSICA; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY CRYSTALLOGRAPHY;

OTOSTEGIA;

EID: 77953943936     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Aronson D (2003). Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffness of aging and diabetes. J. Hypert. 21: 3-12.
2. Muhammed Saeed A, Nessar A (2006). Antiglycation properties of aged garlic extract: role in prevention of diabetic complications, J. Nutri. 3: 3.
3. Rahbar S, Figarola JL (2003). Novel inhibitors of advanced glycation endproducts, Arch. Biochem. Biophys. 419: 63-79.
4. Singh R, Barden A, Mori T, Beilin L (2001). Advanced glycation endproducts: Rev. Diabetologia, 44: 129-146.
5. Ulrich P, Cerami A (2001). Protein glycation, diabetes and aging. Recent Prog. Horm. Res. 56: 1-21.
6. Yassa N, Sharififar F, Shafiee A (2005). Otostegia persica as a source of natural antioxidants. Pharm. Biol. 43(1): 33-38.